Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

ST. LOUIS, Feb. 15, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced that the National Committee for Quality Assurance (NCQA) has awarded Trillium Community Health Plan a Health Plan Accreditation status of "Accredited" for the Medicaid product. The NCQA evaluates how well a health plan manages all parts of its delivery system to continuously improve the quality of care and services provided to its members.

CENTENE OREGON HEALTH PLAN ACHIEVES NCQA ACCREDITATION

ST. LOUIS, Feb. 14, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its subsidiary Louisiana Healthcare Connections was selected by the Louisiana Department of Health to continue administering quality, integrated healthcare services to Medicaid enrollees across the state. The new statewide contract is anticipated to begin July 1, 2022.

Centene Subsidiary Louisiana Healthcare Connections Selected to Continue Serving Louisiana's Medicaid Managed Care Program Statewide

Centene Corporation (CNC) CEO Michael Neidorff on Q4 2021 Results - Earnings Call Transcript

Centene's (CNC) fourth-quarter results indicate improved premium and service revenues coupled with sound membership growth. A solid 2022 guidance should impress investors.

Centene (CNC) Q4 Earnings Beat on Solid Membership Growth

Centene (CNC) delivered earnings and revenue surprises of 3.06% and 0.12%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Centene (CNC) Q4 Earnings Beat Estimates

Centene Corporation CNC has reported Q4 adjusted EPS of $1.01, slightly beating the consensus estimate of $0.99. Get the Inside Access Traders Are Using to Profit More and Win Bigger.

Centene Shares Jump On Better Than Expected Q4 Earnings, Reaffirms FY22 Guidance

Centene Corp. shares CNC, +0.27% rose 2.9% premarket Tuesday, after the managed care company beat estimates for the fourth quarter. The company posted net income of $599 million, or $1.01 a share, for the quarter, after a loss of $12 million, or 2 cents a share, in the year-earlier period.

Centene shares up 2.9% premarket after earnings top estimates

ST. LOUIS, Feb. 8, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its financial results for the fourth quarter and year ended December 31, 2021, reporting diluted earnings per share (EPS) of $1.01 and $2.28, respectively, and adjusted diluted EPS of $1.01 and $5.15, respectively. In summary, the 2021 fourth quarter and full year results were as follows: 2021 Results Q4 Full Year Total revenues (in millions) $             32,568 $           125,982 Premium and service revenues (in millions) $             30,493 $           117,983 Health benefits ratio 87.9% 87.8% SG&A expense ratio 9.3% 8.6% Adjusted SG&A expense ratio (1) 9.2% 8.4% GAAP diluted EPS $                  1.01 $                  2.28 Adjusted diluted EPS (1) $                  1.01 $                  5.15 Total cash flow provided by operations (in millions) $                   675 $                4,205 (1) A full reconciliation of the adjusted SG&A expense ratio and adjusted diluted EPS is shown beginning on page 7 of this release.

CENTENE CORPORATION REPORTS 2021 RESULTS

Centene's (CNC) fourth-quarter results are likely to reflect growth in total membership.

Centene (CNC) Gears Up for Q4 Earnings: What Lies Ahead?

ST. LOUIS, Jan. 31, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that the Centene Institute for Advanced Health Education® ("Centene Institute") has been awarded joint accreditation by three national institutions dedicated to promoting healthcare excellence. In support of improving patient care, the Centene Institute is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for multidisciplinary healthcare teams.

CENTENE INSTITUTE ACHIEVES JOINT ACCREDITATION AS A PROVIDER OF CONTINUING EDUCATION FOR HEALTHCARE TEAMS

SACRAMENTO, Calif.--(BUSINESS WIRE)--A new partnership between San Diego State University's Center for Excellence in Aging & Longevity and Wellcare By Health Net will provide seniors with a holistic approach to navigating the current and emerging challenges faced by older adults and their families. These barriers include social determinants of health, social isolation, and the need to return to a focus on general health and wellness following the COVID-19 pandemic. Central to the partnershi

New San Diego ‘Wellness Club' for Seniors Focused on Peer Learning Launches in Collaboration between SDSU Center for Excellence in Aging & Longevity and Wellcare By Health Net

CF Industries Holdings

Southwest Airlines

Tesla

Exxon Mobil

S&P 500 stocks like CF Industries (CF), Exxon Mobil (XOM), Tesla (TSLA), Centene (CNC) and Southwest Airlines (LUV) are set to post triple-digit earnings growth when they report.

5 S&P 500 Stocks Set to Report Triple-Digits Earnings Growth

SAN FRANCISCO--(BUSINESS WIRE)--Health Net, one of California's longest serving and most experienced Medi-Cal partners, has awarded a $3 million grant to Hazel Health, the national leader in school-based telehealth. The grant will expand access to high quality physical and mental health care for students at 200 K-12 schools in ten California counties. Through Hazel Health's telehealth services, students can connect directly with licensed medical professionals for on-demand care, whether at scho

More California Children Can Access Telehealth at School Thanks to Health Net's $3 Million Grant to Sponsor Hazel Health

SACRAMENTO, Calif.--(BUSINESS WIRE)--Today, Health Net announced the National Committee for Quality Assurance (NCQA) selected the company to help develop NCQA's new Health Equity Accreditation Plus program. Health Net is one of just nine health organizations in the nation selected to help create the new evaluation program. The new program builds on NCQA's recently launched Health Equity Accreditation program that set a robust framework for improving health equity by helping organizations identi

National Committee for Quality Assurance Selects Health Net to Participate in Health Equity Pilot Program

ST. LOUIS, Jan. 10, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2021 fourth quarter and full-year financial results at approximately 6 a.m. Eastern Standard Time (EST) on Tuesday, February 8 th, 2022, and host a conference call afterwards at approximately 8:30 a.m.

REMINDER: CENTENE CORPORATION'S 2021 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS CONFERENCE CALL

SACRAMENTO, Calif.--(BUSINESS WIRE)--Thousands of residents lacking access to food and proper nutrition in Inyo, Mono, and Alpine counties will continue to be served this winter by Inyo Mono Advocates for Community Action (IMACA) thanks to a $25,000 grant from California Health & Wellness (CHW). “In rural communities and food deserts with scarce resources, meeting the nutritional needs of Californians is critical to the health and well-being of our local communities and state,” said Martha

Thousands of California Residents to Receive Food This Winter From Inyo Mono Advocates for Community Action Thanks to a Grant From California Health & Wellness

SACRAMENTO, Calif.--(BUSINESS WIRE)--In response to Gov. Gavin Newsom's declared state of emergency in Amador, Calaveras, El Dorado, Nevada, Placer, Sierra and Yuba counties, California Health & Wellness (CHW) is providing special assistance to members affected by the series of winter storm systems. These systems have produced record-breaking snowfall, damaging winds and flooding. CHW wants to ensure its members have access to essential prescription medications, critical company information

California Health & Wellness Assisting Members Across California During State of Emergency

SACRAMENTO, Calif.--(BUSINESS WIRE)--In response to Gov. Gavin Newsom's declared state of emergency in Los Angeles, Sacramento and San Bernardino counties, Health Net is providing special assistance to ensure members affected by the series of winter storm systems. These systems have produced record-breaking snowfall, damaging winds and flooding. Health Net wants to ensure its members have access to essential prescription medications, critical Health Net information and other healthcare services

Health Net Assisting Members Across California During State of Emergency

ST. LOUIS, Jan. 6, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced that Jim Murray has been appointed as Chief Transformation Officer. Mr. Murray will report to Sarah London, Vice Chairman of the Board for Centene, and will lead Centene's previously announced Value Creation Office and the Centene Advanced Behavioral Health division.

CENTENE APPOINTS JIM MURRAY AS CHIEF TRANSFORMATION OFFICER

ST. LOUIS, Jan. 4, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the JP Morgan 40th Annual Healthcare Conference, to be held virtually January 10-13, 2022. Centene will participate in a virtual format on Monday, January 10 th at 7:30 a.m.

CENTENE TO PRESENT AT 40TH ANNUAL JP MORGAN HEALTHCARE CONFERENCE

ST. LOUIS, Jan. 4, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced that it has completed its acquisition of Magellan Health, Inc. The acquisition enables Centene to provide whole-health, integrated healthcare solutions to deliver better health outcomes at lower costs for complex, high-cost populations. "Magellan will expand Centene's reach to provide increased access to behavioral healthcare for our members at a time when so many Americans are struggling with mental or behavioral health issues," said Michael Neidorff, Chairman and Chief Executive Officer of Centene.

Centene Completes Acquisition of Magellan Health, Establishing a Leading Behavioral Health Platform at a Critical Time

iTeos Therapeutics, Inc.

Magellan Health

NEW YORK, Dec. 31, 2021 /PRNewswire/ -- iTeos Therapeutics Inc. (NASD: ITOS) will replace Magellan Health Inc. (NASD: MGLN) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, January 5. S&P 500 constituent Centene Corp. (NYSE: CNC) is acquiring Magellan Health in a deal expected to be completed soon pending final conditions.

iTeos Therapeutics Set to Join S&P SmallCap 600

Centene's (CNC) acquisition with Magellan Health is likely to close on Jan 4, 2022, around a year after the deal announcement.

Centene (CNC) Receives DMHC Approval for Magellan Acquisition

Centene has an impressive track record of growth, outperforming the S&P 500 over the past 5 and 10 years. It continues to demonstrate strong growth. Plus, demographic tailwinds and the pending Magellan Health acquisition should fuel growth.

Centene: Finally Gets Respect And Is Poised To Profit

ST. LOUIS, Dec. 30, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) and Magellan Health, Inc. (NASDAQ: MGLN) today announced that they have obtained all required regulatory approvals necessary to close Centene's pending acquisition of Magellan Health. Subject to the satisfaction of customary closing deliveries, the parties anticipate closing the acquisition on or about January 4, 2022.

News for Centene Stock (CNC)